Gujarat Kidney Fined ₹6.6 Lakh by NSE & BSE for Delayed Financial Results
Gujarat Kidney And Superspeciality Limited was fined ₹3,30,400 by both NSE and BSE for delayed submission of financial results. The total penalty amounts to ₹6,60,800. The company has already paid the fines.
The company has already paid the fine, and it has stated that there is no further financial impact. The amount of the fine is relatively small for a listed entity.
The company incurred a financial penalty due to non-compliance with listing regulations, which is a negative development.
Gujarat Kidney And Superspeciality Limited (GKSL) has been fined a total of ₹6,60,800 (₹3,30,400 each) by both the National Stock Exchange of India Limited (NSE) and BSE Limited for non-compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company received email notices from NSE and BSE on March 17, 2026, at 7:12 PM and 6:48 PM respectively, informing them of the non-submission of financial results within the prescribed period.
GKSL paid the penalty to both exchanges on March 15, 2026, via RTGS. The company stated that since the payment has been made, there is no further financial impact.
What to do with a filing like this
Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.